Original Research
Published on 09 Nov 2022
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
in Pediatric Oncology

- 2,674 views
- 2 citations
Original Research
Published on 09 Nov 2022
in Pediatric Oncology
Original Research
Published on 08 Nov 2022
in Pediatric Oncology
Original Research
Published on 04 Nov 2022
in Pediatric Oncology
Correction
Published on 02 Nov 2022
in Pediatric Oncology
Brief Research Report
Published on 01 Nov 2022
in Pediatric Oncology
Original Research
Published on 28 Oct 2022
in Pediatric Oncology
Opinion
Published on 14 Oct 2022
in Pediatric Oncology
Original Research
Published on 13 Oct 2022
in Pediatric Oncology
Case Report
Published on 11 Oct 2022
in Pediatric Oncology
Original Research
Published on 10 Oct 2022
in Pediatric Oncology
Perspective
Published on 27 Sep 2022
in Pediatric Oncology
Original Research
Published on 16 Sep 2022
in Pediatric Oncology
Review
Published on 16 Sep 2022
in Pediatric Oncology
Original Research
Published on 12 Sep 2022
in Pediatric Oncology
Review
Published on 06 Sep 2022
in Pediatric Oncology
Original Research
Published on 25 Aug 2022
in Pediatric Oncology